IP Library › Assignment 075614/0936
Patent Assignment
Reel/Frame 075614/0936

RELEASE OF SECURITY INTEREST IN PATENTS, RECORDED ON DECEMBER 10, 2021 AT REEL 058480 FRAME 0221

Recorded: 2026-05-21 Received: 2026-05-21 Pages: 12
Assignor
Assignees
GRIFOLS SHARED SERVICES NORTH AMERICA, INC.
2410 GRIFOLS WAY, LOS ANGELES, CA, 90032, UNITED STATES
GRIFOLS THERAPEUTICS LLC (FORMERLY KNOWN AS GRIFOLS THERAPEUTICS, INC.)
2410 GRIFOLS WAY, LOS ANGELES, CA, 90032, UNITED STATES
GRIFOLS BIOLOGICALS LLC (FORMERLY KNOWN AS GRIFOLS BIOLOGICALS, INC.)
5555 VALLEY BOULEVARD, LOS ANGELES, CA, 90032, UNITED STATES
BIOMAT USA, INC.
2410 LILLYVALE AVENUE, LOS ANGELES, CA, 90032, UNITED STATES
GRIFOLS USA, LLC
C/O GRIFOLS SHARED SERVICES NORTH AMERICA, INC., 2410 GRIFOLS WAY, LOS ANGELES, CA, 90032, UNITED STATES
GRIFOLS WORLDWIDE OPERATIONS USA, INC.
1311 TEMPLE AVENUE, CITY OF INDUSTRY, CA, 91746-1510, UNITED STATES
TALECRIS PLASMA RESOURCES, INC.
2410 LILLYVALE AVENUE, LOS ANGELES, CA, 90032, UNITED STATES
Covered Applications (32)
METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
App. No. 18/518,341
→
COMPOSITION, METHOD, AND KIT FOR ALPHA-1 PROTEINASE INHIBITOR
App. No. 14/926,450
→
IMMUNOCHROMATOGRAPHY DEVICES, METHODS, AND KITS
App. No. 14/803,416
→
COMPOSITIONS, METHODS, AND KITS FOR NUCLEIC ACID HYBRIDIZATION
App. No. 14/237,746
→
TWO-STAGE ULTRAFILTRATION/DIAFILTRATION
App. No. 14/294,460
→
HUMAN ERYTHROVIRUS
App. No. 14/288,691
→
METHODS, COMPOSITIONS, AND KITS FOR DETERMINING HUMAN IMMUNODEFICIENCY VIRUS (HIV)
App. No. 14/221,341
→
METHODS, COMPOSITIONS, AND KITS FOR DETERMINING HUMAN IMMUNODEFICIENCY VIRUS (HIV)
App. No. 14/119,563
→
METHOD FOR DETECTION OF PARVOVIRUS B19
App. No. 14/053,245
→
IMMUNOCHROMATOGRAPHY DEVICES, METHODS AND KITS
App. No. 13/823,505
→
REVERSIBLY INACTIVATED ACIDIFIED PLASMIN COMPOSITION
App. No. 13/761,684
→
Therapeutic Delivery Devices, Systems, and Methods
App. No. 13/581,697
→
VON WILLEBRAND FACTOR (VWF)-CONTAINING PREPARATIONS, AND METHODS, KITS, AND USES RELATED THERETO
App. No. 13/509,309
→
RECOMBINANTLY MODIFIED PLASMIN
App. No. 13/463,437
→
DEVICE FOR MAINTAINING STERILE INTEGRITY OF CONNECTED FLUID PATHWAYS
App. No. 13/262,269
→
RECOMBINANTLY MODIFIED PLASMIN
App. No. 13/302,322
→
COMPOSITIONS, METHODS AND KITS FOR PREPARING PLASMINOGEN AND PLASMIN PREPARED THEREFROM
App. No. 13/147,491
→
Recombinantly Modified Plasmin
App. No. 13/223,373
→
TWO-STAGE ULTRAFILTRATION/DIAFILTRATION
App. No. 12/937,454
→
COMPOSITION, METHOD, AND KIT FOR PREPARING PLASMIN
App. No. 12/995,447
→
RECOMBINANTLY MODIFIED PLASMIN
App. No. 12/744,376
→
METHOD FOR ADJUSTING RESULTS OF A POLYMERASE CHAIN REACTION (PCR) INSTRUMENT
App. No. 12/742,801
→
METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
App. No. 12/741,030
→
METHOD OF TREATMENT AND PROPHYLAXIS OF DISEASES RELATED TO AMYLOID DEPOSITION USING IGM
App. No. 12/162,532
→
RECOMBINANT PLASMIN FOR OPTHALMIC INDICATIONS
App. No. 12/090,782
→
COMPOSITION AND METHOD FOR PREPARING PLASMINOGEN
App. No. 12/399,438
→
REVERSIBLY INACTIVATED ACIDIFIED PLASMIN
App. No. 12/197,617
→
RECOMBINANTLY MODIFIED PLASMIN
App. No. 11/568,023
→
METHOD FOR MELTING FROZEN, WATER-CONTAINING PRODUCTS IN A MIXER
App. No. 10/579,401
→
PROCESS FOR THE PRODUCTION OF A REVERSIBLY INACTIVE ACIDIFIED PLASMIN COMPOSITION
App. No. 10/692,105
→
METHOD OF THROMBOLYSIS BY LOCAL DELIVERY OF REVERSIBLY INACTIVATED ACIDIFIED PLASMIN
App. No. 10/280,444
→
PROCESS FOR VIRAL INACTIVATION OF LYOPHILIZED BLOOD PROTEINS
App. No. 09/894,346
→